BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 31394419)

  • 1. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of MRI-Detectable Boron-Containing Gold Nanoparticle-Encapsulated Biodegradable Polymeric Matrix for Boron Neutron Capture Therapy (BNCT).
    Wu CY; Hsieh HH; Chang TY; Lin JJ; Wu CC; Hsu MH; Lin MC; Peng SL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation.
    Pulagam KR; Gona KB; Gómez-Vallejo V; Meijer J; Zilberfain C; Estrela-Lopis I; Baz Z; Cossío U; Llop J
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591329
    [No Abstract]   [Full Text] [Related]  

  • 4. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
    Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
    Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
    Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
    Meher N; Seo K; Wang S; Bidkar AP; Fogarty M; Dhrona S; Huang X; Tang R; Blaha C; Evans MJ; Raleigh DR; Jun YW; VanBrocklin HF; Desai TA; Wilson DM; Ozawa T; Flavell RR
    ACS Appl Mater Interfaces; 2021 Nov; 13(46):54739-54752. PubMed ID: 34752058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
    Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
    Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice.
    Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B
    Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Chemo-Radiotherapy with Rod-Shaped and Spherical Gold Nano Probes: Shape and Active Targeting Both Matter.
    Zhang L; Su H; Wang H; Li Q; Li X; Zhou C; Xu J; Chai Y; Liang X; Xiong L; Zhang C
    Theranostics; 2019; 9(7):1893-1908. PubMed ID: 31037146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
    Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects.
    Gao Z; Horiguchi Y; Nakai K; Matsumura A; Suzuki M; Ono K; Nagasaki Y
    Biomaterials; 2016 Oct; 104():201-12. PubMed ID: 27467416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography.
    Balcerzyk M; De-Miguel M; Guerrero C; Fernandez B
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932575
    [No Abstract]   [Full Text] [Related]  

  • 18. Engineering Novel Targeted Boron-10-Enriched Theranostic Nanomedicine to Combat against Murine Brain Tumors via MR Imaging-Guided Boron Neutron Capture Therapy.
    Kuthala N; Vankayala R; Li YN; Chiang CS; Hwang KC
    Adv Mater; 2017 Aug; 29(31):. PubMed ID: 28620939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer.
    Kubota T; Kuroda S; Kanaya N; Morihiro T; Aoyama K; Kakiuchi Y; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Fujiwara T
    Nanomedicine; 2018 Aug; 14(6):1919-1929. PubMed ID: 29885899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of EGFR-targeted radioimmuno-gold-nanoparticles as a theranostic agent in a tumor animal model.
    Kao HW; Lin YY; Chen CC; Chi KH; Tien DC; Hsia CC; Lin MH; Wang HE
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3180-5. PubMed ID: 23628334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.